PTPN11 and malignant colon neoplasm: In xenograft studies using adult lung, pancreas, or colon cancer cell lines, SHP2 inhibitors enhanced the efficacy of covalent KRASG12C inhibitors [18,114] and both SHP2 [113,137] and SOS1 [135] inhibitors enhanced the efficacy of MEK inhibitors.